Skip to content

AMICUS THERAPEUTICS, INC.

Delisted

CIK 1178879fmd_0B508M6WA0JY5RDR16HRGBGTPJManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2003 to Dec 31, 2025, 70 periods

Latest annual · FY2025

Millions
Total revenues
634
Gross profit
561
Operating income
33
Net income
(27)
Free cash flow
30

Latest quarter · Q4 FY2025

Millions
Total revenues
185
Gross profit
159
Operating income
16
Net income
2
Free cash flow
16
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+24.4%
Revenue, 5 yearsFY2020 to FY2025
+19.4%
Net income, 5 yearsFY2020 to FY2025
n/m

AMICUS THERAPEUTICS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$634.2 million$528.3 million+20%10-K 2026-02-20 · proof
Gross profit$561.3 million$475.4 million+18.1%10-K 2026-02-20 · proof
Operating income$32.8 million$24.9 million+31.8%10-K 2026-02-20 · proof
Net income-$27.1 million-$56.1 million10-K 2026-02-20 · proof
Cash from operating activities$33.1 million-$33.9 million10-K 2026-02-20 · proof
Free cash flow$29.8 million-$37.4 million10-K 2026-02-20 · proof
Total assets$949.9 million$785 million+21%10-K 2026-02-20 · proof
Total liabilities$675.6 million$591 million+14.3%10-K 2026-02-20 · proof
Cash and cash equivalents$214 million$213.8 million+0.1%10-K 2026-02-20 · proof
What was AMICUS THERAPEUTICS, INC.'s revenue in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported revenue of $634.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $528.3 million the year before (+20%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What was AMICUS THERAPEUTICS, INC.'s gross profit in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported gross profit of $561.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $475.4 million the year before (+18.1%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What was AMICUS THERAPEUTICS, INC.'s operating income in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported operating income of $32.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $24.9 million the year before (+31.8%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What was AMICUS THERAPEUTICS, INC.'s net income in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported net income of -$27.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$56.1 million the year before. Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What was AMICUS THERAPEUTICS, INC.'s cash from operating activities in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported cash from operating activities of $33.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$33.9 million the year before. Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What was AMICUS THERAPEUTICS, INC.'s free cash flow in fiscal 2025?
AMICUS THERAPEUTICS, INC. reported free cash flow of $29.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$37.4 million the year before. Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What are AMICUS THERAPEUTICS, INC.'s total assets?
As of Dec 31, 2025, AMICUS THERAPEUTICS, INC. reported total assets of $949.9 million, against $785 million a year earlier (+21%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What are AMICUS THERAPEUTICS, INC.'s total liabilities?
As of Dec 31, 2025, AMICUS THERAPEUTICS, INC. reported total liabilities of $675.6 million, against $591 million a year earlier (+14.3%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC
What are AMICUS THERAPEUTICS, INC.'s cash and cash equivalents?
As of Dec 31, 2025, AMICUS THERAPEUTICS, INC. reported cash and cash equivalents of $214 million, against $213.8 million a year earlier (+0.1%). Source: the 10-K filed with the SEC on Feb 20, 2026. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1178879&period_type=annual&limit=5"

Information only, not investment advice.